Jessica Lange, MD
Otolaryngology · Lexington, KYNPI 1760746150
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,272 of the $1,731 with a category attached, or 73.5%. Stryker accounts for 65.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $693 and has fallen 73.5% since, to $184 in 2025.
Across 41 payments — averaging $42.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Intersect ENT, Inc.$169
- GSK$78
- Regeneron Healthcare Solutions, Inc.$54
- Optinose US, Inc.$48
- Merck$42
- plus $203 from 9 others
What the payments were for
- Travel & lodging$45927%
- Food & beverage$1,27273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 18 | $1,138 |
| Intersect ENT, Inc. | 2 | $169 |
| GSK | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Optinose US, Inc. | 2 | $48 |
| Merck | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $40 |
| Acclarent, Inc | 1 | $29 |
| Smith+Nephew | 1 | $29 |
| Medtronic | 2 | $27 |
| AbbVie | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Alk-abello, Inc | 1 | $14 |
| Aerin Medical Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$459
- XPRESS ENT DILATION SYSTEM$245
- PROPEL$146
How this compares
$1,731 in reported general payments places this provider in the 55th percentile of 137 otolaryngology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 51 | $2,775 |
| Azelastine Hcl | 104 | $2,218 |
| Ofloxacin | 34 | $1,253 |
| Fluticasone Propionate | 125 | $1,240 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 12 | $1,175 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 16 | $615 |
| Omeprazole | 79 | $389 |
| Mupirocin | 65 | $311 |
| Montelukast Sodium | 43 | $225 |
| Doxycycline Monohydrate | 15 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $209 |
| Famotidine | 20 | $163 |
| Methylprednisolone | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Lexington
- Thomas GalLexington$21K
- Brian HixonLexington$8K
- Sanford ArcherLexington$6K
- David AlexanderLexington$6K
- Quinn DunlapLexington$6K
- Ray van MetreLexington$5K
- Joseph ValentinoLexington$5K
- Kenneth HughesLexington$4K
- Greg OsetinskyLexington$3K
- Alberto LaureanoLexington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.